Abstract
The survival of clonogenic cells in the B16 melanoma has been studied simultaneously by 3 methods: an in vitro assay in soft agar, a lung-colony assay, and the end-point dilution technique. Details of the first 2 methods have previously been reported, but those of the third are described here. The 3 methods have agreed well in investigations of the response of the B16 melanoma to cyclophosphamide.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Steel, G., Adams, K. & Stephens, T. Clonogenic assays in the B16 melanoma: response to cyclophosphamide. Br J Cancer 36, 618–624 (1977). https://doi.org/10.1038/bjc.1977.239
Issue Date:
DOI: https://doi.org/10.1038/bjc.1977.239